2006
DOI: 10.1590/s0066-782x2006001800027 View full text |Buy / Rent full text
|
|

Abstract: Phosphodiesterase inhibitors like sildenafil have already been shown to improve functional capacity and hemodynamics in the treatment of pulmonary arterial hypertension. Few studies address the effects of new phosphodiesterase inhibitors as tadalafil. We report a case of a patient with idiopathic pulmonary arterial hypertension in functional class IV (New York Heart Association) with significant response to treatment with tadalafil.

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
5
0
1

Publication Types

Select...

Relationship

0
0

Authors

Journals